EU Secondary Data Post-Authorisation Safety Study of AZD1222

Clinical trial NCT05126992 · COMPLETED

Trial details

NCT number: NCT05126992
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19, Vaccine Adverse Events of Special Interest

Start date: 2022-02-18
Primary completion: 2024-01-24
Enrollment: 5321930

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.